Hudson Bay Capital Management
PHIO icon

Hudson Bay Capital Management’s Phio Pharmaceuticals PHIO Stock Holding History

Hudson Bay Capital Management’s Portfolio PHIO Stock Details PHIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Hold
0
– -$13K – 497
2017
Q2 		– Hold
0
– – – 502
2017
Q1 		– Sell
-4
Closed -$153K – 891
2016
Q4 		$153K Buy
+4
New +$313K ﹤0.01% 600

Other funds holding PHIO

PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Hudson Bay Capital Management's PHIO Position: Q3 2017 in Review

Hudson Bay Capital Management held its Phio Pharmaceuticals (PHIO) position steady in Q3 2017 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #497.

Hudson Bay Capital Management first reported a position in PHIO in Q4 2016 and has held it in 1 quarter since. The position peaked at $153K in Q4 2016. 3 funds tracked by Wall St. Rank hold PHIO as of Q3 2017.

  • Hudson Bay Capital Management held 0 shares of Phio Pharmaceuticals worth $0 as of Q3 2017.
  • Hudson Bay Capital Management left its Phio Pharmaceuticals share count unchanged in Q3 2017.
  • Phio Pharmaceuticals made up ﹤0.01% of Hudson Bay Capital Management's portfolio in Q3 2017, its #497 holding.
  • Hudson Bay Capital Management first reported a position in Phio Pharmaceuticals in Q4 2016 and has held it in 1 quarter since.
  • Hudson Bay Capital Management's Phio Pharmaceuticals position peaked at $153K in Q4 2016.
  • 3 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q3 2017.

Based on Hudson Bay Capital Management's 13F filing for Q3 2017, filed 13 Nov 2017.